You're receiving this email because you're subscribed to Future Finance from Benzinga. To manage your subscription, click the link at the bottom of this email.

Happy Monday!

Bitcoin could be bottoming, and may ‘do well’ over the rest of the year, according to Tom Lee.

Strategy has bought more Bitcoin, and a lot! Here’s how much Michael Saylor’s company purchased last week.

Plus, VSee believes it is building something big in the $787 billion digital healthcare playground! Schedule a demo today at Vseehealth.com and find out how their solutions could transform your organization's patient care. Stay current with the latest VSee Health news and SEC filings by clicking here. 

TOP STORY

Tom Lee Says 'We've Got The Right Pieces For A Bottom,' Bitcoin 'Could Do Well Into Year-End'

“I think it’s possible that instead of us breaking down here and seeing markets under further pressure, we’ve actually got the right pieces for a bottom,” said Tom Lee, Fundstrat’s Head of Research and Chief Investment Officer.

“People are buying cars and wine ahead of tariffs, and that’s distorting inflation,” Lee observed. “But if you factor in some of the positive effects like lower gas prices and interest rates, we might actually see better growth.”

So, what does he see for Bitcoin’s future?

Read the full scoop here.

SPONSORED CONTENT

VSee Health: Revolutionizing Healthcare Brick By Brick

VSee Health (NASDAQ: VSEE) is building the future brick by digital brick through their "LEGO-like" telehealth platform that allows ultimate customizability. The platform is helping to transform care at NASA, in Qatar and for healthcare giants like McKesson.

With telepresence robots rolling through hospitals and tech that speaks 240+ languages, VSee isn't just in the digital healthcare market—they're working on rewriting the rulebook. Handling 1.5 million HIPAA-compliant video encounters monthly, their broader vision is to make healthcare more accessible for everyone.

VSee believes it is building something big in the $787 billion digital healthcare playground! Schedule a demo today at Vseehealth.com and find out how their solutions could transform your organization's patient care. Stay current with the latest VSee Health news and SEC filings. 

This is a paid ad. Please see 17b disclosure here for more information.

QUICK N DIRTY

Bitcoin mining is the next crypto endeavor the Trump family is getting in on after their DeFi and meme coin projects. What are Eric and Don Jr. planning?

Raoul Pal remains bullish and thinks a fresh Bitcoin rally is imminent: here’s his price target.

Dogecoin will not be used for the purposes of D.O.G.E., according to chief DOGE advocate Elon Musk.

FINTECH FOCUS

Strategy Acquires 22,048 More Bitcoin For $1.92 Billion, Bringing Total Holdings To 528,185 BTC

Strategy Incorporated on Monday announced it has significantly expanded its cryptocurrency portfolio by acquiring 22,048 Bitcoin for $1.92 billion between March 24 and March 30 at an average price of $86,969 per BTC.

The company now holds a total of 528,185 BTC, purchased at an average cost of $67,458 per coin, amounting to a total investment of approximately $35.63 billion.

How much money does Strategy have left to buy Bitcoin?

Read the full scoop here.

BEFORE YOU GO

Were you forwarded this email? Click here to subscribe.

And be sure to check out our other newsletters:

Ring The Bell: Created for market enthusiasts by market enthusiasts, this daily newsletter delivers top stories, fast movers and hot trade ideas straight to your inbox. Subscribe here.

Cannabis Daily: A must-read daily briefing for cannabis investors, operators and enthusiasts. Join our list of industry veterans to jump start your morning. Subscribe here.

Advisor: Tailor-made for Financial Advisors, this weekly newsletter has industry-specific insights, analysis and news. Subscribe here.

Tech Trends: Get the inside scoop on AI, the hottest gadgets and mind-blowing tech trends. Subscribe here.

Disclaimer: This communication from Benzinga is for informational purposes only. It is not intended to serve as a recommendation to buy, sell, or hold any security and is not an offer or sale of a security. Information contained within should not be perceived as a research report and is not intended to serve as the basis for any investment decision. Any third-party views reflected herein do not reflect the opinion of Benzinga. All investments involve risk and the past performance of a security does not guarantee future results or returns. There is always the potential for financial loss when investing in securities or other financial products. Investors should consider their investment objectives and risks before investing. Benzinga is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Benzinga may receive monetary compensation from the issuer, or its agency, for publicizing the offering of the issuer’s securities. This content is for informational purposes only and is not intended to be investing advice. This is a paid ad. Please see 17b disclosure linked in the campaign page for more information.